Skip to main content
Clinical Trials/NCT06451224
NCT06451224
Completed
Not Applicable

Attitudes of Prophylactic Antibiotic Utilization During Primary Total Hip and Knee Arthroplasty Among Egyptian Joint Replacement Surgeons

South Valley University1 site in 1 country105 target enrollmentJune 15, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Infections Joint Prosthetic
Sponsor
South Valley University
Enrollment
105
Locations
1
Primary Endpoint
To determine the type of antibiotics administration during primary total hip and knee arthroplasty
Status
Completed
Last Updated
last year

Overview

Brief Summary

Total hip arthroplasty (THA) and total knee arthroplasty (TKA) are procedures successfully applied to manage various end-stage chronic hip and knee diseases, such as osteoarthritis, rheumatoid arthritis, and femoral head avascular necrosis, as well as acute conditions, such as the neck of femur fractures, with excellent long-term functional outcomes. One of the devastating complications after such a procedure is periprosthetic joint infection (PJI). Various precautions are proposed to guard against such complications; one is the administration of perioperative antibiotics. However, injudicious or misuse of antibiotics could lead to the emergence of antimicrobial resistance, further complicating this matter. This is why various scientific and research organizations have proposed guidelines and a consensus for proper antibiotic use in perioperative THA and TKA surgery.

Antibiotic prophylaxis during primary THA and TKA can reduce the risk of PJI and surgical site infections. However, there is a lack of consensus on the optimal dosages and duration of prophylaxis, and guidelines vary among institutions. Alternatives such as extended oral antibiotic prophylaxis and different antibiotic regimens are being explored. International research is needed to establish best practices and determine the potential risks of antibiotic prophylaxis during primary THA and TKA. Unfortunately, the investigators are unaware of such guidelines proposed by any Egyptian health authority to guide and control the proper utilization of antibiotics during orthoapedic practice in general and joint replacement surgeries (THA and TKA) in particular.

Detailed Description

This study will be an Online-based questionnaire investigating surgeons' perspectives on antibiotics utilization during primary total hip and knee arthroplasty surgeries and investigate their thoughts about the necessity for developing local guidelines.

Registry
clinicaltrials.gov
Start Date
June 15, 2024
End Date
September 30, 2024
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ahmed A. Khalifa, MD, FRCS, MSc

Assistant Professor

South Valley University

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

To determine the type of antibiotics administration during primary total hip and knee arthroplasty

Time Frame: 2 months

The type of antibiotics will be determined as follows: the name of the antibiotic (brand or generic), and if single or dual antibiotics are used. These will be presented as numbers and percentages.

Secondary Outcomes

  • To determine the dose of antibiotics administered during primary total hip and knee arthroplasty(2 months)
  • To determine the length of antibiotics administration during primary total hip and knee arthroplasty(2 months)
  • To determine the timing of antibiotics administration during primary total hip and knee arthroplasty(2 months)

Study Sites (1)

Loading locations...

Similar Trials